C18:1-Ceramide

• UNSPSC Description:

  C18:1-Ceramide is a ceramide subspecies. C18:1-Ceramide can be used in the study of type 2 diabetes[1]

• Target Antigen:

  Endogenous Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/c18-1-ceramide.html

• Solubility:

  10 mM in DMSO|DMF : ≥ 100 mg/mL

• Smiles:

  CCCCCCCC/C=C\CCCCCCCC(N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC)=O

• Molecular Weight:

  563.94

• References & Citations:

  [1]Haus, Jacob M et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes vol. 58,2 (2009): 337-43.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  5966-28-9